BiondVax, MonoSol team up on oral flu vaccine; Intercell fell due to poor sales of vax against Japanese encephalitis;

@AlisonBFierce: U. of Minnesota researchers call for a better flu vaccine, but say financial risk throws up roadblocks. More | Follow @AlisonBFierce

> Researchers will test four experimental HIV vaccines in a region in South Africa where one in 5 adults is infected with HIV. More

> New Australian research shows the national cervical cancer vaccination program is eliminating most cases of genital warts, a leading cause of the cancer. Story

> Despite a West Nile virus outbreak and deaths caused by the disease, the realization of a human vaccine seems distant. News

> Dutch researchers took a look at the plausibility of inhaled vaccines. Article

> Intercell stock fell after the company warned its only marketable product, a vaccine against Japanese encephalitis, hadn't sold as much as anticipated. Item

> Genticel announced positive data from its Phase I trial in women infected with high-risk HPV before appearance of cervical lesions. Release

> Novavax reported positive results from two Phase II trials of pandemic influenza vaccine. Release

> St. Louis University's Center for Vaccine Development is beginning a clinical trial to test different doses of a new pneumonia vaccine, PCV13 Prevnar, in older adults. Report

And Finally... BiondVax Pharmaceuticals and MonoSol Rx have teamed up on an oral flu vaccine. News

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.